Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma

Area of Science:

• Neuro-oncology
• Molecular Biology
• Genetics

Background:

• Diffuse intrinsic pontine gliomas (DIPGs) are aggressive pediatric brain tumors with poor prognosis.
• Surgical resection is not feasible due to tumor location in the brainstem.
• Current treatments offer limited survival benefits for DIPG patients.

Purpose of the Study:

• To identify genetic alterations in DIPG tumors.
• To explore potential therapeutic targets for DIPG.

Main Methods:

• Whole-exome sequencing of DIPG tumor samples.
• Analysis of ACVR1 gene mutations.
• Comparison with known genetic mutations in other diseases.

Main Results:

• Recurrent activating mutations in the ACVR1 gene were identified in 21% of DIPG samples.
• These mutations, including specific substitutions (e.g., p.Arg206His), are identical to those found in fibrodysplasia ossificans progressiva (FOP).
• The identified ACVR1 mutations constitutively activate the BMP-TGF-β signaling pathway.

Conclusions:

• ACVR1 mutations represent a novel molecular finding in DIPG.
• These mutations are potential therapeutic targets for treating DIPG.
• Targeting the BMP-TGF-β pathway could offer new treatment strategies for this devastating childhood cancer.